Shaomei Li Selected Research

Shaomei Li Research Topics

3	Neoplasms (Cancer) 09/2022 - 12/2016
2	Chronic Renal Insufficiency 11/2023 - 01/2022
2	Infections 01/2022 - 03/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2019
2	Mucoepidermoid Carcinoma 01/2019 - 05/2017
1	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2023
1	Anemia 11/2023
1	Peritonitis 07/2023
1	Asthma (Bronchial Asthma) 03/2022
1	Adenocarcinoma of Lung 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Lupus Nephritis 01/2022
1	Ureteral Obstruction 09/2019
1	Fibrosis (Cirrhosis) 09/2019
1	Hypertension (High Blood Pressure) 10/2018
1	Lymphatic Metastasis 08/2016
1	Liver Diseases (Liver Disease) 03/2016
1	Proteinuria 03/2016
1	Kidney Diseases (Kidney Disease) 10/2015

3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
2	Tacrolimus (Prograf)FDA LinkGeneric 12/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 09/2019 - 08/2016
2	Gefitinib (Iressa)FDA Link 01/2019 - 05/2017
1	Rituximab (Mabthera)FDA Link 12/2023
1	Erythropoietin FDA Link 11/2023
1	Epoetin Alfa (Epogen)FDA Link 11/2023
1	Peptides (Polypeptides)IBA 11/2023
1	Hemoglobins (Hemoglobin)IBA 07/2023
1	C-Reactive ProteinIBA 09/2022
1	Adenosine DeaminaseIBA 09/2022
1	Therapeutic UsesIBA 03/2022
1	aflutinibIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	anlotinibIBA 10/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2019
1	CollagenIBA 09/2019
1	rheinIBA 09/2019
1	Antihypertensive Agents (Antihypertensives)IBA 10/2018
1	Cyclin D1IBA 12/2016
1	MicroRNAs (MicroRNA)IBA 12/2016
1	LipidsIBA 03/2016
1	SteroidsIBA 03/2016
1	CreatinineIBA 10/2015

2	Renal Dialysis (Hemodialysis) 07/2023 - 01/2022
2	Therapeutics 03/2022 - 10/2019
1	Drug Therapy (Chemotherapy) 03/2022
1	Bronchial Thermoplasty 03/2022
1	Peritoneal Dialysis 01/2022
1	Catheters 01/2022
1	Aftercare (After-Treatment) 03/2016
1	Length of Stay 10/2015